InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by John Minardo, Directeur Juridique. Officer active across 1 company, notably Ironwood Pharmaceuticals INC. In total, 16 filings have been recorded. Split: 0 buy · 8 sells. Total volume traded: €1.1m. Activity tracked since 2 August 2021. The latest transaction was disclosed on 10 March 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to John Minardo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
136,612 shares0Class A Common StockSEC:0001193125-26-104108:0
17,439 shares@ US$3.815.3% of flowClass A Common StockSEC:0001193125-26-071509:0
7,754 shares@ US$0.840.6% of flowClass A Common StockSEC:0000950170-25-108013:0
122,222 shares0Class A Common StockSEC:0000950170-25-019234:0
40,187 shares0Class A Common StockSEC:0000950170-25-007815:0
9,910 shares@ US$4.273.9% of flowClass A Common StockSEC:0000950170-24-097189:0
17,404 shares@ US$6.4510.4% of flowClass A Common StockSEC:0000950170-24-063480:0
32,752 shares0Class A Common StockSEC:0000950170-24-029908:0
47,380 shares@ US$15.2467.1% of flowClass A Common StockSEC:0000950170-24-015560:0
79,981 shares0Class A Common StockSEC:0001209191-24-001904:0
7,045 shares@ US$10.046.5% of flowClass A Common StockSEC:0001209191-23-046017:0
65,502 shares0Class A Common StockSEC:0001209191-23-017883:0
3,282 shares@ US$11.413.6% of flowClass A Common StockSEC:0001209191-23-014277:0
7,330 shares@ US$11.778.5% of flowClass A Common StockSEC:0001209191-22-046220:0
67,873 shares0Class A Common StockSEC:0001209191-22-016185:0
79,892 shares0Class A Common StockSEC:0001209191-21-049604:0
16 of 16 declarations
About John Minardo
John Minardo is Chief Legal Officer at Ironwood Pharmaceuticals INC. Across 16 filings, and in the 16 sampled filings, all transactions are sales, for a total sale amount of EUR 1057706, observed between 2021-08-04 and 2026-03-12.
